.
During the clinical session, everything clicked on what was supposed to be happening with treatment…I really feel like I know what I am doing.

– Joshua Sussal, MD; Greenbelt, MD
.

 

.
I was debating having my own separate TMS practice and after Total TMS, I’ve decided I am definitely going to. The clinical session was excellent and very motivating.– David Aversa, MD; Connecticut Psychiatric and Wellness Center
.
.
The educational weekend was great. Very thorough! The speakers have been very approachable and the training session was informative and hands-on.– Kelly Cowan, MD; San Antonio, TX
.
.
Provided valuable, practical knowledge to bring TMS to psychiatry in the community. I am excited to be able to provide TMS as an effective treatment for depression in my psychiatric practice.– Melissa De Jesus Quinn, MD; San Antonio, TX
.
.
An excellent program covering all aspects of providing TMS in a clinical program. The hands-on practicum with the ability to see the equipment working and determining motor threshold and stimulus treating point was very helpful.
– Louis B. Cady, MD; Cady Wellness Institute, Newburgh, IN
.
.
A must do – provides the nut-n-bolts of how to successfully structure a TMS practice. I am now able to sleep because we have a step-by-step plan for “how” to bring this technology to our patients. Everyone shared their knowledge and truly wanted to give us the tools to succeed. There was an amazing sense of family, mutual support and excitement for our patients.

– Laura Notorangelo, RN; Hope by the Bay, Harbor Springs, MI
.

 

All trademarks are the property of Neuronetics, Inc.

*NeuroStar TMS Therapy® is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.

In a randomized controlled trial, patients receiving active NeuroStar TMS Therapy were four times more likely to achieve remission compared to patients receiving sham treatment (P = 0.0173; odds ratio = 4.05)1

The most common side effect is pain or discomfort at or near the treatment site.2 These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. NeuroStar TMS Therapy is contraindicated in patients with non-removable conductive metal in or near the head.

NeuroStar TMS Therapy is available by prescription only. For full prescribing and safety information, please visit www.NeuroStar.com or call Neuronetics Customer Service at 1-877-600-7555.

1) George, MS, et al. (2010). Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder A Sham-Controlled Randomized Trial. Arch Gen Psychiatry. 67(5): 507-516.
2) Janicak, PG, et al. (2008) Transcranial Magnetic Stimulation (TMS) in the Treatment of Major Depression: A Comprehensive Summary of Safety Experience from Acute and Extended Exposure and During Reintroduction Treatment. J Clin Psychiatry, 69(2):222-232.